Calumet Statistics
Total Valuation
Calumet has a market cap or net worth of $3.44 billion. The enterprise value is $5.59 billion.
| Market Cap | 3.44B |
| Enterprise Value | 5.59B |
Important Dates
The last earnings date was Friday, August 7, 2026, before market open.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Calumet has 87.15 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Current Share Class | 87.15M |
| Shares Outstanding | 87.15M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 3.21% |
| Owned by Institutions (%) | 39.03% |
| Float | 58.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 89.00 |
| PS Ratio | 0.76 |
| Forward PS | 0.74 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 47.25 |
| P/OCF Ratio | 23.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.46, with an EV/FCF ratio of 76.49.
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | 22.46 |
| EV / EBIT | 82.43 |
| EV / FCF | 76.49 |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | 9.02 |
| Debt / FCF | 30.73 |
| Interest Coverage | 0.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.32% |
| Return on Invested Capital (ROIC) | -3.48% |
| Return on Capital Employed (ROCE) | 4.30% |
| Weighted Average Cost of Capital (WACC) | 7.80% |
| Revenue Per Employee | $2.98M |
| Profits Per Employee | -$88,831 |
| Employee Count | 1,540 |
| Asset Turnover | 1.65 |
| Inventory Turnover | 10.80 |
Taxes
| Income Tax | -135.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +159.40% in the last 52 weeks. The beta is 0.71, so Calumet's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +159.40% |
| 50-Day Moving Average | 38.01 |
| 200-Day Moving Average | 28.70 |
| Relative Strength Index (RSI) | 46.12 |
| Average Volume (20 Days) | 1,290,455 |
Short Selling Information
The latest short interest is 3.66 million, so 4.20% of the outstanding shares have been sold short.
| Short Interest | 3.66M |
| Short Previous Month | 4.29M |
| Short % of Shares Out | 4.20% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 3.81 |
Income Statement
In the last 12 months, Calumet had revenue of $4.59 billion and -$136.80 million in losses. Loss per share was -$1.57.
| Revenue | 4.59B |
| Gross Profit | 317.80M |
| Operating Income | -58.80M |
| Pretax Income | -272.10M |
| Net Income | -136.80M |
| EBITDA | 250.30M |
| EBIT | 68.20M |
| Loss Per Share | -$1.57 |
Balance Sheet
The company has $109.80 million in cash and $2.26 billion in debt, with a net cash position of -$2.15 billion or -$24.66 per share.
| Cash & Cash Equivalents | 109.80M |
| Total Debt | 2.26B |
| Net Cash | -2.15B |
| Net Cash Per Share | -$24.66 |
| Equity (Book Value) | -886.50M |
| Book Value Per Share | -12.94 |
| Working Capital | -194.00M |
Cash Flow
In the last 12 months, operating cash flow was $146.10 million and capital expenditures -$72.60 million, giving a free cash flow of $73.50 million.
| Operating Cash Flow | 146.10M |
| Capital Expenditures | -72.60M |
| Depreciation & Amortization | 142.10M |
| Net Borrowing | -52.60M |
| Free Cash Flow | 73.50M |
| FCF Per Share | $0.84 |
Margins
Gross margin is 6.92%, with operating and profit margins of -1.28% and -2.98%.
| Gross Margin | 6.92% |
| Operating Margin | -1.28% |
| Pretax Margin | -5.93% |
| Profit Margin | -2.98% |
| EBITDA Margin | 5.45% |
| EBIT Margin | 1.49% |
| FCF Margin | 1.60% |
Dividends & Yields
Calumet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.02% |
| Shareholder Yield | -1.02% |
| Earnings Yield | -3.94% |
| FCF Yield | 2.12% |
Analyst Forecast
The average price target for Calumet is $39.60, which is 0.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $39.60 |
| Price Target Difference | 0.30% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 8.94% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |